SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001437749-23-024291
Filing Date
2023-08-21
Accepted
2023-08-21 16:15:51
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 sabs20230731_s3.htm S-3 250135
2 EXHIBIT 5.1 ex_552207.htm EX-5.1 8638
3 EXHIBIT 23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_552208.htm EX-23.1 2339
4 EXHIBIT FILING FEES ex_552209.htm EX-FILING FEES 23002
5 dentonslogo.jpg GRAPHIC 5716
  Complete submission text file 0001437749-23-024291.txt   293196
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274119 | Film No.: 231189286
SIC: 2836 Biological Products, (No Diagnostic Substances)